Galapagos

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Galapagos and other ETFs, options, and stocks.

About GLPG

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. 

CEO
Paulus Stoffels
CEOPaulus Stoffels
Employees
1,338
Employees1,338
Headquarters
Mechelen, Brussels Region
HeadquartersMechelen, Brussels Region
Founded
1999
Founded1999
Employees
1,338
Employees1,338

GLPG Key Statistics

Market cap
2.13B
Market cap2.13B
Price-Earnings ratio
9.49
Price-Earnings ratio9.49
Dividend yield
Dividend yield
Average volume
111.32K
Average volume111.32K
High today
$33.10
High today$33.10
Low today
$31.88
Low today$31.88
Open price
$32.15
Open price$32.15
Volume
302.69K
Volume302.69K
52 Week high
$45.21
52 Week high$45.21
52 Week low
$31.86
52 Week low$31.86

GLPG News

TipRanks 49m
Galapagos NV Welcomes New Board Member

Galapagos NV (GLPG) has released an update. Galapagos NV has strengthened its board by appointing Andrew Dickinson, the Chief Financial Officer of Gilead Scien...

Analyst ratings

67%

of 12 ratings
Buy
33.3%
Hold
66.7%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.